3 Japanese AI Healthcare Stocks Worth Watching Now

With inflation trends diverging across regions, central banks reassessing rate paths, and energy prices still tied to geopolitics, many investors are looking for themes grounded in real-world problem solving rather than short term sentiment. Transformative AI Healthcare stocks fit that brief by focusing on companies that apply artificial intelligence to diagnostics, treatment decisions, hospital efficiency, and drug discovery. This screener filters for businesses using AI to target accuracy, access, and cost in healthcare, an area where small improvements can matter at a global scale. Below, you will see 3 stocks from this Transformative AI Healthcare screener to research further.

ASO International (TSE:9340)

Overview: ASO International is a Japan based dental orthodontics company that develops and supplies a wide range of specialist products, from lingual and clear aligner systems to 3D printed appliances and AI supported scanning and modeling services for clinics.

Market Cap: ¥7.0b

ASO International provides exposure to how AI and digital workflows are reshaping dental care, with products that span clear aligners, lingual systems, 3D printing and an AI powered scanning platform that can support more precise and efficient orthodontic treatment. The stock trades below one estimate of fair value and carries a modest P/E relative to local medical equipment peers, which may appeal to investors who focus on paying a disciplined price for growth. At the same time, the balance sheet relies entirely on external borrowing and governance data is limited, so funding risk and board oversight are key issues to watch closely as the company approaches upcoming earnings updates.

ASO International’s mix of clear aligners, 3D printing and AI scanning could make the current P/E and balance sheet questions look very different. Review the ASO International financial health report to see what might be hiding in plain sight.

eWeLLLtd (TSE:5038)

Overview: eWeLLLtd runs a cloud platform that handles the day to day paperwork, billing, reporting and training needs of home based nursing providers in Japan, with tools ranging from electronic medical records and insurance claim systems to attendance tracking, AI supported nursing reports, factoring services and e learning.

Operations: eWeLLLtd currently generates all of its ¥3,592 million in revenue from providing services to home visit nursing stations in Japan.

Market Cap: ¥31.1b

eWeLLLtd operates in AI healthcare with a focus on the infrastructure of home based care, using software and AI powered reporting to make visiting nurse stations more efficient and easier to run. Earnings and revenue have both been growing, profitability metrics such as net margins and return on equity are high, and the company has been returning some capital through share buybacks and a rising dividend. At the same time, the stock’s P/E is higher than many local peers and the balance sheet depends entirely on external borrowing, so pricing, funding risk and governance quality all deserve closer inspection before deciding how eWeLLLtd might fit into a portfolio.

eWeLLLtd’s high margins, growing earnings and rising dividend hint at a story that the headline P/E does not fully capture, and the full picture in the analyst forecasts for eWeLLLtd may surprise you.

FINDEX (TSE:3649)

Overview: FINDEX is a Japan based healthcare IT company that builds software and devices for hospitals and clinics, from electronic medical records and image filing to referral management, remote information sharing and AI supported medical text generation.

Operations: FINDEX generates almost all of its ¥6.1b in revenue in Japan, with the Medical Business contributing roughly ¥5,771.8m, Public Sector Business ¥268.4m and Health Tech Business ¥108.0m.

Market Cap: ¥21.5b

FINDEX brings AI into everyday hospital workflows, pairing tools like electronic medical records, imaging systems and generative AI for medical text with a track record of high quality earnings, net margins above 20% and strong returns on equity around 22% to 23%. Forecasts point to earnings growth that is faster than the broader Japanese market and local healthcare services peers. The stock trades below one estimate of fair value and at a P/E under the regional industry average. The main caution flag is funding risk, with all liabilities coming from external borrowing and only 36% of board seats classed as independent. This makes FINDEX a case where the upside story and the governance and funding details both deserve a closer look before deciding how it fits in a portfolio.

FINDEX pairs high quality earnings with an under industry P/E that could be masking something important in the story. Get the full context in the analysis report for FINDEX and see what the governance and funding mix might really mean.

The three stocks covered here are just a starting point, and the full Transformative Artificial intelligence (AI) Healthcare Stocks screener uncovers four more companies with AI driven healthcare stories that could be just as compelling. Use Simply Wall St to identify and analyze the catalysts that matter most to you, from diagnostic accuracy and personalized treatment to hospital efficiency and remote care narratives, so you can focus on the highest conviction ideas in this theme.

Take Control of Your Investment Journey

If ASO International or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Before They Fly?

Fresh stock ideas do not stay under the radar for long. Spot potential breakouts with real momentum before the crowd catches on and pricing shifts, then act now.

• Target income that can support your plan by scanning a curated set of high yield opportunities with the 43 dividend fortresses before payouts or prices shift away.
• Track where real computing breakthroughs could emerge by reviewing the hand picked 26 quantum computing stocks while expectations are still forming and sentiment has not fully caught up.
• Get ahead of early infrastructure winners by assessing companies in the carefully filtered 52 AI infrastructure stocks before AI spending patterns reshape the story.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com